QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2021    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Inhibition of Autophagy by a Small Molecule through Covalent Modification of the LC3 Protein 期刊论文 ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 页码: 11 作者:  Fan, Shijie;  Yue, Liyan;  Wan, Wei;  Zhang, Yuanyuan;  Zhang, Bidong 收藏  |  浏览/下载：80/0  |  提交时间：2021/12/16 covalent modification  probes  proteome  LC3  post-translational modification   Define Mesenchymal Stem Cell from Its Fate: Biodisposition of Human Mesenchymal Stem Cells in Normal and Concanavalin A-Induced Liver Injury Mice 期刊论文 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 卷号: 379, 期号: 2, 页码: 125-133 作者:  Han, Li;  Ma, Chenhui;  Peng, Huige;  Wu, Zhitao;  Xu, Huiming 收藏  |  浏览/下载：26/0  |  提交时间：2022/01/04 The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability 期刊论文 MOLECULAR CELL, 2021, 卷号: 81, 期号: 13, 页码: 2736-+ 作者:  Pan, Qiang;  Zhong, Shanshan;  Wang, Hanling;  Wang, Xuege;  Li, Ni 收藏  |  浏览/下载：76/0  |  提交时间：2021/11/04 SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target 期刊论文 CELL RESEARCH, 2021, 页码: 14 作者:  Xia, Bingqing;  Shen, Xurui;  He, Yang;  Pan, Xiaoyan;  Liu, Feng-Liang 收藏  |  浏览/下载：78/0  |  提交时间：2021/08/17 Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 215, 页码: 12 作者:  Lin, Tingting;  Li, Jiacheng;  Liu, Liping;  Li, Yuanqing;  Jiang, Hualiang 收藏  |  浏览/下载：71/0  |  提交时间：2021/05/24 CDK2 inhibitor  Selectivity  Anti-proliferative potency   Structural insights into the lipid and ligand regulation of serotonin receptors 期刊论文 NATURE, 2021, 页码: 25 作者:  Xu, Peiyu;  Huang, Sijie;  Zhang, Huibing;  Mao, Chunyou;  Zhou, X. Edward 收藏  |  浏览/下载：25/0  |  提交时间：2021/05/24 A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia 期刊论文 Alzheimer's Research & Therapy, 2021, 卷号: 13, 期号: 1 作者:  Xiao,Shifu;  Chan,Piu;  Wang,Tao;  Hong,Zhen;  Wang,Shuzhen 收藏  |  浏览/下载：149/0  |  提交时间：2021/05/24 Sodium oligomannate  Efficacy  Safety  Alzheimer’s disease  Clinical trial   PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma 期刊论文 THERANOSTICS, 2021, 卷号: 11, 期号: 11, 页码: 5387-5403 作者:  Wang, Jianfeng;  Wang, Chen;  Xu, Pan;  Li, Xiao;  Lu, Yongning 收藏  |  浏览/下载：130/0  |  提交时间：2021/05/24 clear cell renal cell carcinoma  protein arginine methyltransferase 1  therapeutic  lipocalin2 (LCN2)  sunitinib